DBV Technologies DBVT 深 沪
已收盘 11-13 16:00:00 美东时间
11.015
-0.415
-3.63%
华盛通- 最 高11.99
- 今 开11.37
- 成交量 27.89万股
- 最 低 10.51
- 昨 收 11.43
- 总市值 6.93亿
- 52周最高 26.185
- 市盈率 静 --
- 换手率 0.44%
- 52周最低 8.63
- 委 比 -99.83%
- 总股本 6287.78万
- 历史最高 505.70
- 量 比 0.93
- 振 幅 12.95%
- 历史最低 2.2045
- 每 手 1
- 风险率 4.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多DBV Technologies收跌3.79%，成交额389.55万美元
11月13日，DBV Technologies（DBVT）收跌3.79%，报11.43美元，成交额389.55万美元，市值7.18亿美元。 行情数据 • 开盘价...
11-13 07:00
DBV Technologies Reports Additional VITESSE Data for VIASKIN® Peanut Patch
DBV Technologies ( ($FR:DBV) ) has shared an update. DBV Technologies reported ...
11-12 23:40
DBV Technologies Highlights New Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years
DBV Technologies announced new data from the VITESSE Phase 3 study of the VIASKIN® Peanut Patch in peanut-allergic children aged 4-7 years. The study showed statistically significant reductions in reaction severity during food challenges, high treatment compliance (96.1%), and immunologic changes consistent with allergen immunotherapy. These findings were presented at the 2026 ACAAI Annual Scientific Meeting, highlighting the potential practicali...
11-12 15:00
DBV Technologies收跌1.41%，成交额402.33万美元
11月6日，DBV Technologies（DBVT）收跌1.41%，报9.8美元，成交额402.33万美元，市值6.16亿美元。 行情数据 • 开盘价：1...
11-06 06:57
美股大行评级 | 潜在涨幅1112.12%！Canaccord Genuity上调Wave Life Sciences目标价至44美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences"买入"评级，目标价从42美元升至44美元；Canaccord Genuity：维持Pharming Group"买入"评级，目标价从38美元升至41美元
10-30 12:30
DBV Technologies收跌3.38%，成交额1060.38万美元
10月30日，DBV Technologies（DBVT）收跌3.38%，报10.29美元，成交额1060.38万美元，市值6.47亿美元。 行情数据 • 开盘...
10-30 05:58
DBV Technologies Q3 2026 Earnings Call Transcript
DBV Technologies (NASDAQ:DBVT) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzin...
10-29 05:47
DBV Technologies Q3 EPS $(0.14) Beats $(0.24) Estimate, Sales $1.600M Beat $820.000K Estimate
DBV Technologies (NASDAQ:DBVT) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.24) by 41.67 percent. This is a 41.67 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $1.600 millio...
10-29 04:53
DBV Technologies to Report Third Quarter 2026 Financial Results and Business Update on October 28, 2026
DBV Technologies will release its third quarter 2026 financial results and business update on October 28, 2026, at 5:00 p.m. ET, with a live conference call and webcast available to investors. The company, focused on developing treatments for food allergies using its VIASKIN® patch technology, is headquartered in France and listed on Euronext and Nasdaq. Interested parties can join via the provided phone numbers or the webcast link on the company...
10-27 20:30
DBV Technologies收涨1.48%，成交额1372.16万美元
10月22日，DBV Technologies（DBVT）收涨1.48%，报9.62美元，成交额1372.16万美元，市值6.05亿美元。 行情数据 • 开盘价...
10-22 06:03
